NOVAVAX INC Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVAVAX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NOVAVAX INC for August 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | A | 19.08 | 125,000 | 2,385,000 | 125,000 | |
| Aug 26 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 19.08 | 140,000 | 2,671,200 | 140,000 | |
| Aug 26 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 19.08 | 165,000 | 3,148,200 | 165,000 | |
| Aug 26 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 19.08 | 400,000 | 7,632,000 | 400,000 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 46.00 | 10,410 | 478,860 | 14,589 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.60 | 13,322 | 367,687 | 6,677 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.00 | 1,952 | 52,704 | 4,298 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.00 | 5,855 | 158,085 | 394 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 99.80 | 11,249 | 1,122,650 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 153.95 | 1,300 | 200,135 | 5,087 | 6.4 K to 5.1 K (-20.35 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 153.16 | 1,708 | 261,597 | 6,387 | 8.1 K to 6.4 K (-21.10 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 152.22 | 4,199 | 639,172 | 8,095 | 12.3 K to 8.1 K (-34.15 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 150.85 | 4,010 | 604,909 | 12,294 | 16.3 K to 12.3 K (-24.60 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 149.83 | 1,800 | 269,694 | 16,304 | 18.1 K to 16.3 K (-9.94 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 149.08 | 6,600 | 983,928 | 18,104 | 24.7 K to 18.1 K (-26.72 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 147.99 | 9,101 | 1,346,857 | 24,704 | 33.8 K to 24.7 K (-26.92 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 146.95 | 8,094 | 1,189,413 | 33,805 | 41.9 K to 33.8 K (-19.32 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 146.21 | 4,900 | 716,429 | 41,899 | 46.8 K to 41.9 K (-10.47 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 143.99 | 300 | 43,197 | 46,799 | 47.1 K to 46.8 K (-0.64 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 142.85 | 776 | 110,852 | 47,099 | 47.9 K to 47.1 K (-1.62 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 46.00 | 10,410 | 478,860 | 47,875 | 37.5 K to 47.9 K (+27.79 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.60 | 13,322 | 367,687 | 37,465 | 24.1 K to 37.5 K (+55.18 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.00 | 1,952 | 52,704 | 24,143 | 22.2 K to 24.1 K (+8.80 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.00 | 5,855 | 158,085 | 22,191 | 16.3 K to 22.2 K (+35.84 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 99.80 | 11,249 | 1,122,650 | 16,336 | 5.1 K to 16.3 K (+221.13 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Sell | S | 146.00 | 8,000 | 1,168,000 | 9,951 | 18 K to 10 K (-44.57 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Buy | M | 27.60 | 4,000 | 110,400 | 17,951 | 14 K to 18 K (+28.67 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Buy | M | 27.60 | 4,000 | 110,400 | 13,951 | 10 K to 14 K (+40.20 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 46.00 | 8,328 | 383,088 | 11,671 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 27.60 | 13,322 | 367,687 | 6,677 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 27.00 | 1,952 | 52,704 | 4,298 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 27.00 | 393 | 10,611 | 394 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 99.80 | 11,249 | 1,122,650 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 91.00 | 2,499 | 227,409 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 36.60 | 7,499 | 274,463 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Sell | S | 144.79 | 21,648 | 3,134,414 | 275 | 21.9 K to 275 (-98.75 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Sell | S | 143.92 | 24,594 | 3,539,568 | 21,923 | 46.5 K to 21.9 K (-52.87 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 46.00 | 8,328 | 383,088 | 46,517 | 38.2 K to 46.5 K (+21.81 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 27.60 | 13,322 | 367,687 | 38,189 | 24.9 K to 38.2 K (+53.57 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 27.00 | 1,952 | 52,704 | 24,867 | 22.9 K to 24.9 K (+8.52 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 27.00 | 393 | 10,611 | 22,915 | 22.5 K to 22.9 K (+1.74 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 99.80 | 11,249 | 1,122,650 | 22,522 | 11.3 K to 22.5 K (+99.79 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 91.00 | 2,499 | 227,409 | 11,273 | 8.8 K to 11.3 K (+28.48 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 36.60 | 7,499 | 274,463 | 8,774 | 1.3 K to 8.8 K (+588.16 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, Chief Legal Of ... | Buy | M | 50.00 | 1,000 | 50,000 | 1,275 | 275 to 1.3 K (+363.64 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 46.00 | 13,225 | 608,350 | 18,524 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.60 | 16,658 | 459,761 | 8,341 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.00 | 2,733 | 73,791 | 6,017 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.00 | 8,200 | 221,400 | 550 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 36.60 | 4,405 | 161,223 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 25.60 | 7,500 | 192,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 50.00 | 3,200 | 160,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Gift | G | 0.00 | 1,528 | 0 | 311 | 1.8 K to 311 (-83.09 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 146.58 | 525 | 76,955 | 1,839 | 2.4 K to 1.8 K (-22.21 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 146.00 | 17,151 | 2,504,046 | 2,364 | 19.5 K to 2.4 K (-87.89 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 145.00 | 31,957 | 4,633,765 | 19,515 | 51.5 K to 19.5 K (-62.09 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 143.94 | 6,288 | 905,095 | 51,472 | 57.8 K to 51.5 K (-10.89 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 46.00 | 13,225 | 608,350 | 57,760 | 44.5 K to 57.8 K (+29.70 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.60 | 16,658 | 459,761 | 44,535 | 27.9 K to 44.5 K (+59.76 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.00 | 2,733 | 73,791 | 27,877 | 25.1 K to 27.9 K (+10.87 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.00 | 8,200 | 221,400 | 25,144 | 16.9 K to 25.1 K (+48.39 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 36.60 | 4,405 | 161,223 | 16,944 | 12.5 K to 16.9 K (+35.13 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 25.60 | 7,500 | 192,000 | 12,539 | 5 K to 12.5 K (+148.84 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 50.00 | 3,200 | 160,000 | 5,039 | 1.8 K to 5 K (+174.01 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 27.60 | 4,000 | 110,400 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 36.60 | 1,500 | 54,900 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 150.44 | 10,500 | 1,579,620 | 321,979 | 332.5 K to 322 K (-3.16 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 27.60 | 4,000 | 110,400 | 332,479 | 328.5 K to 332.5 K (+1.22 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 27.60 | 4,000 | 110,400 | 328,479 | 324.5 K to 328.5 K (+1.23 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 36.60 | 1,500 | 54,900 | 324,479 | 323 K to 324.5 K (+0.46 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 50.00 | 1,000 | 50,000 | 322,979 | 322 K to 323 K (+0.31 %) |